Cargando…
P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429083/ http://dx.doi.org/10.1097/01.HS9.0000846492.51234.76 |
| _version_ | 1784779323786395648 |
|---|---|
| author | Groen, K. Seefat, M. R. van der Holt, B. Schjesvold, F. H. Stege, C. A. Levin, M.-D. Hansson, M. Leys, R. B. Regelink, J. Waage, A. Szatkowski, D. Axelsson, P. Do, T. H. Svirskaite, A. van der Spek, E. Haukas, E. Knut-Bojanowska, D. Ypma, P. F. Blimark, C. Mellqvist, U.-H. van de Donk, N. W. Sonneveld, P. Klostergaard, A. Vangsted, A. J. Abdilgaard, N. Zweegman, S. |
| author_facet | Groen, K. Seefat, M. R. van der Holt, B. Schjesvold, F. H. Stege, C. A. Levin, M.-D. Hansson, M. Leys, R. B. Regelink, J. Waage, A. Szatkowski, D. Axelsson, P. Do, T. H. Svirskaite, A. van der Spek, E. Haukas, E. Knut-Bojanowska, D. Ypma, P. F. Blimark, C. Mellqvist, U.-H. van de Donk, N. W. Sonneveld, P. Klostergaard, A. Vangsted, A. J. Abdilgaard, N. Zweegman, S. |
| author_sort | Groen, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429083 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290832022-08-31 P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 Groen, K. Seefat, M. R. van der Holt, B. Schjesvold, F. H. Stege, C. A. Levin, M.-D. Hansson, M. Leys, R. B. Regelink, J. Waage, A. Szatkowski, D. Axelsson, P. Do, T. H. Svirskaite, A. van der Spek, E. Haukas, E. Knut-Bojanowska, D. Ypma, P. F. Blimark, C. Mellqvist, U.-H. van de Donk, N. W. Sonneveld, P. Klostergaard, A. Vangsted, A. J. Abdilgaard, N. Zweegman, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429083/ http://dx.doi.org/10.1097/01.HS9.0000846492.51234.76 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Groen, K. Seefat, M. R. van der Holt, B. Schjesvold, F. H. Stege, C. A. Levin, M.-D. Hansson, M. Leys, R. B. Regelink, J. Waage, A. Szatkowski, D. Axelsson, P. Do, T. H. Svirskaite, A. van der Spek, E. Haukas, E. Knut-Bojanowska, D. Ypma, P. F. Blimark, C. Mellqvist, U.-H. van de Donk, N. W. Sonneveld, P. Klostergaard, A. Vangsted, A. J. Abdilgaard, N. Zweegman, S. P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 |
| title | P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 |
| title_full | P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 |
| title_fullStr | P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 |
| title_full_unstemmed | P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 |
| title_short | P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13 |
| title_sort | p905: ixazomib-thalidomide-dexamethasone induction followed by ixazomib or placebo maintenance in non-transplant eligible newly diagnosed multiple myeloma patients; long-term results of hovon-126/nmsg 21.13 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429083/ http://dx.doi.org/10.1097/01.HS9.0000846492.51234.76 |
| work_keys_str_mv | AT groenk p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT seefatmr p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vanderholtb p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT schjesvoldfh p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT stegeca p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT levinmd p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT hanssonm p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT leysrb p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT regelinkj p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT waagea p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT szatkowskid p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT axelssonp p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT doth p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT svirskaitea p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vanderspeke p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT haukase p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT knutbojanowskad p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT ypmapf p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT blimarkc p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT mellqvistuh p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vandedonknw p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT sonneveldp p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT klostergaarda p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT vangstedaj p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT abdilgaardn p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 AT zweegmans p905ixazomibthalidomidedexamethasoneinductionfollowedbyixazomiborplacebomaintenanceinnontransplanteligiblenewlydiagnosedmultiplemyelomapatientslongtermresultsofhovon126nmsg2113 |